Ocugen Inc (OCGN)
$6.71
0.11 (1.61%)
OCGN Stock Quote Delayed 30 Minutes
Is Ocugen Worth a Shot Because of the Worsening Pandemic?
While OCGN stock seems like a reasonable speculation based on the worsening Covid-19 crisis, it’s still a tough gamble.
Louis Navellier's Top 6 Stocks for 2021
He found Apple at $1.49… Intel at $3.60... Amazon at $46. Now, investing legend Louis Navellier is revealing his Top 6 Stocks for 2021 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
1.33B
PE Ratio
-23.96
EPS
-0.28
Volume (Avg. Vol.)
7.10M
Day's Range
6.67 - 6.93
52-Week Range
0.25 - 18.77
Dividend & Yield
N/A (N/A)
OCGN Stock Predictions, Articles, and Ocugen Inc News
9 Lesser-Known Short-Squeeze Stocks Popular With Retail Investors
We're taking a look at some of the lesser-known short-squeeze stocks popular with retail investors that should be on your radar.
Ocugen’s Recent Vaccine Efficacy Results Should Have Traders Cheering
While the Delta variant Covid-19 strain threatens the population, OCGN stock investors can count on Ocugen to advance its vaccine candidate.
The Outlook for Ocugen Stock Has Deteriorated Further
Phase 3 data on Covaxin wasn't outstanding, and there are indications that demand for additional vaccines in the U.S. and Canada will be low for some time. OCGN remains a good stock to short.
3 Reasons Ocugen Stock Should Maintain Its Upward Trajectory
OCGN stock has been counted out of the vaccine race many times, but there is plenty of room for optimism moving forward.
What Will the Stock Market Do Today? 3 Big Stories to Watch.
So what will the stock market do today? All eyes are on Didi stock and r/WallStreetBets drama from this weekend.
OCGN Stock: The Big Covaxin News That Has Ocugen Rallying Today
Ocugen's Indian vaccine development partner reported better-than-expected results from its local Covid-19 vaccine trials. OCGN stock has been on a roller-coaster ride on every Covaxin rumor and news item.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're getting right back into the swing of things today after the weekend with a look at the biggest pre-market stock movers for Tuesday!
Don’t Play the Ocugen Stock Short Squeeze Before You Read This Warning!
While the contrarian bullish argument for OCGN stock has picked up considerable chatter, this is an extremely risky trade.
Ocugen Has Had a Good Run, but the Math Says It’s Over
Ocugen was a penny stock is up 180% for the year. But all good things must come to an end. And it’s time to let go of OCGN stock.
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
So what did the stock market do today? All eyes were on the Robinhood fines and moves by Coinbase to embrace DeFi.
Sell Ocugen Stock Before the Other Shoe Finally Drops
The bad news with Covaxin hasn't sunk in yet with OCGN stock investors, so get out while the stock still remains elevated.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning! We're taking a look at the biggest pre-market stock movers for Wednesday and that includes the winners and losers.
If Ocugen Stock Is Worth $8, I’ll Eat My Hat
The class-action lawsuits against Ocugen are getting prepared by lawyers. Trading at $8.35, OCGN stock looks ready to take a fall.
Ocugen Stock Is A Bust After Covaxin’s Emergency Use Rejection
OCGN stock is of no value to investors now that federal regulators closed the door on its Covid-19 vaccine commercialization efforts.
Get Rid of Ocugen Stock While You Can as the Bad News Piles Up
After OCGN stock rallied due to factors that were not based on fundamentals, investors should sell the shares.
It’s Time to Admit Defeat and Dump Ocugen Stock as a Covid Play
After the FDA rejected Covaxin, Ocugen has almost no chance of generating profits from the shot. OCGN stock is a great short.
OCGN Stock: Ocugen Fans Should Be Cheering This COVAXIN News
OCGN stock saw a glimmer of hope today. Where the company took a hit last week in deserting EUA, it is gaining today with a new partnership.
